Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left

Keiichi Hirono1, Yukiko Hata2, Nariaki Miyao1

  • 1Departments of Pediatrics (K.H., N.M., M.O., S.T., H.N., K.I., S.O., F.I.), Graduate School of Medicine, University of Toyama, Japan.

Insights

Ion channel gene variants are linked to arrhythmias in pediatric left ventricular noncompaction (LVNC). This genetic insight aids in managing children with this hereditary heart condition.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Left ventricular noncompaction (LVNC) is a hereditary cardiomyopathy with significant morbidity and mortality.
  • Genetic underpinnings, particularly ion channel gene variants, in pediatric LVNC remain incompletely understood.

Purpose of the Study:

  • To investigate the ion channel genetic landscape in pediatric LVNC.
  • To identify genotype-phenotype correlations in a large Japanese cohort of children with LVNC.

Main Methods:

  • A cohort of 206 children diagnosed with LVNC between 2002 and 2017 in Japan was studied.
  • Patients were classified based on LVNC presentation (e.g., congenital heart defects, arrhythmia, dilated phenotype, normal function).
  • Next-generation sequencing was employed to screen 182 cardiomyopathy-associated genes.

Main Results:

  • Pathogenic variants were identified in 40 genes in 87 patients, with 8.8% in ion channel genes.
  • Ion channel variants predominantly correlated with arrhythmia phenotypes, while sarcomere and mitochondrial variants were linked to dilated phenotypes.
  • Patients with ion channel variants showed a higher risk of arrhythmias like ventricular tachycardia and near-normal LV function parameters.

Conclusions:

  • This study is the first to explore genotype-phenotype correlations in pediatric LVNC focusing on ion channel variants.
  • Ion channel gene variants show a strong association with arrhythmia phenotypes in pediatric LVNC.
  • Genetic testing and precise phenotype characterization are crucial for targeted medical management in LVNC patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
252
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
328
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
371
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
311
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
204